HIT Consultant July 17, 2024
Fred Pennic

What You Should Know:

– Thyme Care, a leading value-based cancer care enabler raises $95M in funding capital led by Concord Health Partners, with participation from existing investors including CVS Health® Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Foresite Capital, and new investor SignalFire. The funding brings Thyme Care’s total funding to $178M.

– Thyme Care is a value-based cancer care enabler focused on improving patient outcomes and reducing healthcare costs. The new funding will fuel Thyme Care’s expansion into new markets, deepen existing partnerships, and enhance its clinical value-based care model.

Addressing the Cancer Care Crisis

The cancer care landscape is marked by escalating costs, fragmented care, and significant disparities in patient...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Investments, Payment Models, Trends, Value Based
Related Articles:
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing?
Cityblock Health Validates Value-Based Care Arrangement with 11.5% Payer Expense Reduction
Podcast: What Direction Will Alternative Payment Models Head Over the Next Four Years? 11/21/24

Share This Article